# Assessment of Inhibition of Biofilm Formation and Plaque Bacterial Count of Fluoride Varnish Containing Chlorhexidine and Cetylpyridinium Chloride Versus Conventional Fluoride Varnish

> **NCT04254835** · PHASE4 · UNKNOWN · sponsor: **Cairo University** · enrollment: 34 (estimated)

## Conditions studied

- High Caries Risk Patients

## Interventions

- **DRUG:** Cervitec F, Ivoclar Vivadent - Schaan Liechtenstein
- **DRUG:** Fluor Protector, Ivoclar Vivadent - Schaan Liechtenstein

## Key facts

- **NCT ID:** NCT04254835
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04254835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04254835, "Assessment of Inhibition of Biofilm Formation and Plaque Bacterial Count of Fluoride Varnish Containing Chlorhexidine and Cetylpyridinium Chloride Versus Conventional Fluoride Varnish". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04254835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*